IGM-2 TINA-QUANT IGM GEN.2

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-01-25 for IGM-2 TINA-QUANT IGM GEN.2 manufactured by Roche Diagnostics.

Event Text Entries

[65710382] This event occurred in (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[65710383] The customer stated that they received erroneous results for one patient sample tested for igm-2 tina-quant igm gen. 2 (igm) on a cobas 6000 c (501) module - c501. The customer stated that results were higher when running the sample without dilution and with automatic dilution versus results obtained with a dilution directly ordered on the analyzer. An erroneous result may have been reported outside of the laboratory. The sample initially resulted as 41. 86 g/l accompanied by a data flag. The sample was repeated with a reduced sample volume, resulting as 58. 70 g/l accompanied by a data flag. The sample was repeated a second time without dilution, resulting as 30. 18 g/l accompanied by a data flag. The sample was repeated a third time with a 1:2 dilution ordered on the analyzer, resulting with a raw value of 27. 74 g/l. The printout of the result indicated that it was run with reduced sample volume. When multiplied by a dilution factor of 2, the final result was 55. 48 g/l. The sample was repeated a fourth time without dilution, resulting as 41. 86 g/l accompanied by a data flag. The sample was repeated a fifth time with a 1:5 dilution ordered on the analyzer, resulting as 0. 50 g/l. This value was reported outside of the laboratory. The sample was repeated a sixth time on (b)(6) 2017 with a 1:5 manual dilution, resulting with a raw value of 12. 04 g/l accompanied by a data flag. The sample was repeated a seventh time on (b)(6) 2017 with a 1:5 manual dilution, resulting with a raw value of 10. 80 g/l. The printout of the result indicated that it was run with reduced sample volume. When multiplied by a dilution factor of 5, the final result was 54 g/l. The sample was repeated an eighth time on (b)(6) 2016 with a 1:5 dilution ordered on the analyzer, resulting with a raw value of 0. 46 g/l. The patient was not adversely affected. The serial number of the c501 analyzer was (b)(4). The igm application requires a pre-dilution of 1:21. This dilution is programmed in the application. When the user programs a dilution of the sample directly on the analyzer, this dilution overrides the required 1:21 pre-dilution. For example, when the user programmed a 1:5 dilution on the analyzer, the analyzer made a 1:5 dilution of the sample, but did not make the required 1:21 dilution, resulting in the analyzer testing a sample that was approximately 4 times too concentrated for this application. This issue is covered in product labeling. The result obtained in this case may be subject to a high dose hook effect. The result of 0. 5 g/l may therefore be incorrect. By ordering a dilution directly on the system the customer disabled the required pre-dilution step. When the customer made a manual dilution before placing the sample on the analyzer, the analyzer made the required 1:21 pre-dilution in addition to the manual dilution made by the customer. The result of 54 g/l may be correct, but this could not be determined based on the available information. A specific root cause could not be determined based on the provided information. Additional information required for the investigation was asked for, but not provided.
Patient Sequence No: 1, Text Type: D, B5


[67569316] With regards to the following statements in the initial medwatch : "the sample was repeated a sixth time on (b)(6) 2017 with a 1:5 manual dilution, resulting with a raw value of 12. 04 g/l accompanied by a data flag. The sample was repeated a seventh time on (b)(6) 2017 with a 1:5 manual dilution, resulting with a raw value of 10. 80 g/l. The printout of the result indicated that it was run with reduced sample volume. When multiplied by a dilution factor of 5, the final result was 54 g/l. " it was clarified that the sample was manually diluted with nacl to obtain the result of 12. 04 g/l accompanied by a data flag. The sample was then automatically repeated at a reduced sample volume to obtain the repeat value of 10. 80 g/l. The operator's manual describes the process of ordering dilutions and informs users that selecting a dilution on the analyzer will overwrite the pre-programmed dilution for the test.
Patient Sequence No: 1, Text Type: N, H10


[68620430] Medwatch field d4 lot number has been updated.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2017-00138
MDR Report Key6276012
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-01-25
Date of Report2017-02-24
Date of Event2016-12-29
Date Mfgr Received2017-01-04
Date Added to Maude2017-01-25
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameIGM-2 TINA-QUANT IGM GEN.2
Generic NameIGM (MU CHAIN SPECIFIC)
Product CodeDAO
Date Received2017-01-25
Model NumberNA
Catalog NumberASKU
Lot Number172445
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2017-01-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.